SCHEMBL6091238

SCHEMBL6091238

CCN(C)c1nc2c(cc1CN(Cc1cc(F)cc(F)c1)c1nnn(C)n1)c(C)nn2CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5624206 0.93 CETP (0.36)
SCHEMBL5629586 0.89 CETP (0.35)
SCHEMBL5624926 0.85
SCHEMBL5628490 0.84 CETP (0.36)
SCHEMBL19179892 0.83
SCHEMBL19178251 0.82
SCHEMBL16969511 0.80
SCHEMBL6091240 0.80 CETP (0.34)
SCHEMBL5624109 0.78 GRIA2 (0.32)
SCHEMBL5624197 0.78 CETP (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1848430-B1 NOVEL BENZYLAMINE DERIVATIVES AS CETP INHIBITORS Dr Reddys Laboratories Ltd (IN) 2017-08-02 EP disclosed
US-9040558-B2 Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors DR. REDDY'S LABORATORIES LTD. (IN) 2015-05-26 US disclosed
US-20060178514-A1 Novel benzylamine derivatives as CETP inhibitors DR. REDDY'S LABORATORIES LTD. (IN) 2006-08-10 US disclosed